High tumor mast cell density is associated with longer survival of colon cancer patients

References

• Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. Cancer J Clin 2015;65:87–108.
   PubMed Web of Science ®Google Scholar
• Ekbom A, Helmick C, Zack M, Adami HO. Ulcerative colitis and colorectal cancer. A population-based study. N Eng J Med 1990;323:1228–33.
   PubMed Web of Science ®Google Scholar
• Terzic J, Grivennikov S, Karin E, Karin M. Inflammation and colon cancer. Gastroenterology 2010;138:2101–14.
   PubMed Web of Science ®Google Scholar
• Heijmans J, Buller NV, Muncan V, van den Brink GR. Role of mast cells in colorectal cancer development, the jury is still out. Biochimica Et Biophysica Acta 2012;1822:9–13.
   PubMed Web of Science ®Google Scholar
• Galli SJ, Borregaard N, Wynn TA. Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils. Nat Immunol 2011;12:1035–44.
   PubMed Web of Science ®Google Scholar
• Caughey GH. Mast cell tryptases and chymases in inflammation and host defense. Immunol Rev 2007;217:141–54.
   PubMed Web of Science ®Google Scholar
• Maltby S, Khazaie K, McNagny KM. Mast cells in tumor growth: angiogenesis, tissue remodelling and immune-modulation. Biochimica Et Biophysica Acta 2009;1796:19–26.
   PubMed Web of Science ®Google Scholar
• Kanaoka Y, Boyce JA. Cysteinyl leukotrienes and their receptors: cellular distribution and function in immune and inflammatory responses. J Immunol (Baltimore, Md: 1950) 2004;173:1503–10.
   PubMed Web of Science ®Google Scholar
• Magnusson C, Mezhybovska M, Lörinc E, Fernebro E, Nilbert M, Sjölander A. Low expression of CysLT1R and high expression of CysLT2R mediate good prognosis in colorectal cancer. Eur J Cancer 2010;46:826–35.
   PubMed Web of Science ®Google Scholar
• Theron AJ, Steel HC, Tintinger GR, Gravett CM, Anderson R, Feldman C. Cysteinyl leukotriene receptor-1 antagonists as modulators of innate immune cell function. J Immunol Res 2014;2014:608930.
   PubMed Web of Science ®Google Scholar
• Nielsen HJ, Hansen U, Christensen IJ, Reimert CM, Brunner N, Moesgaard F. Independent prognostic value of eosinophil and mast cell infiltration in colorectal cancer tissue. J Pathol 1999;189:487–95.
   PubMed Web of Science ®Google Scholar
• Tan SY, Fan Y, Luo HS, Shen ZX, Guo Y, Zhao LJ. Prognostic significance of cell infiltrations of immunosurveillance in colorectal cancer. World J Gastroenterol 2005;11:1210–14.
   PubMed Web of Science ®Google Scholar
• Acikalin MF, Oner U, Topcu I, Yasar B, Kiper H, Colak E. Tumour angiogenesis and mast cell density in the prognostic assessment of colorectal carcinomas. Digest Liver Dis 2005;37:162–9.
   Web of Science ®Google Scholar
• Gulubova M, Vlaykova T. Prognostic significance of mast cell number and microvascular density for the survival of patients with primary colorectal cancer. J Gastroenterol Hepatol 2009;24:1265–75.
   PubMed Web of Science ®Google Scholar
• Sinnamon MJ, Carter KJ, Sims LP, Lafleur B, Fingleton B, Matrisian LM. A protective role of mast cells in intestinal tumorigenesis. Carcinogenesis 2008;29:880–6.
   PubMed Web of Science ®Google Scholar
• Li L, Dang Q, Xie H, Yang Z, He D, Liang L, et al. Infiltrating mast cells enhance prostate cancer invasion via altering LncRNA-HOTAIR/PRC2-androgen receptor (AR)-MMP9 signals and increased stem/progenitor cell population. Oncotarget 2015;6:14179–90.
   PubMed Web of Science ®Google Scholar
• Böckelman C, Engelmann BE, Kaprio T, Hansen TF, Glimelius B. Risk of recurrence in patients with colon cancer stage II and III: a systematic review and meta-analysis of recent literature. Acta Oncologica 2015;54:5–16.
   PubMed Web of Science ®Google Scholar
• Birgisson H, Talbäck M, Gunnarsson U, Påhlman L, Glimelius B. Improved survival in cancer of the colon and rectum in Sweden. Eur J Surg Oncol 2005;31:845–53.
   PubMed Web of Science ®Google Scholar
• Greene FL, Page DL, Fleming ID, Fritz AG, Balch CM, Haller DG, et al. eds. AJCC Cancer Staging Manual. 6th ed., New York: Springer; 2002.
   Google Scholar
• Maekawa A, Austen KF, Kanaoka Y. Targeted gene disruption reveals the role of cysteinyl leukotriene 1 receptor in the enhanced vascular permeability of mice undergoing acute inflammatory responses. J Biol Chem 2002;277:20820–4.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Sime W, Juhas M, Sjölander A. Crosstalk between colon cancer cells and macrophages via inflammatory mediators and CD47 promotes tumour cell migration. Eur J Cancer 2013;49:3320–34.
   PubMed Web of Science ®Google Scholar
• Barderas R, Villar-Vazquez R, Fernandez-Acenero MJ, Babel I, Pelaez-Garcia A, Torres S, et al. Sporadic colon cancer murine models demonstrate the value of autoantibody detection for preclinical cancer diagnosis. Sci Rep 2013;3:2938.
   PubMed Web of Science ®Google Scholar
• Özdemir Ö. Immunosurveillance function of human mast cells? World Journal of Gastroenterology 2005;11:7054–6.
   PubMed Web of Science ®Google Scholar
• Rigoni A, Colombo MP, Pucillo C. The role of mast cells in molding the tumor microenvironment. Cancer Microenvironment 2015;8:167–76.
   PubMed Web of Science ®Google Scholar
• Wang D, DuBois RN. Eicosanoids and cancer. Nat Rev Cancer 2010;10:181–93.
   PubMed Web of Science ®Google Scholar
• Savari S, Chandrashekar NK, Osman J, Douglas D, Bellamkonda K, Jönsson G, et al. Cysteinyl leukotriene 1 receptor influences intestinal polyp incidence in a gender-specific manner in the ApcMin/+ mouse model. Carcinogenesis 2016;37:491–9.
   PubMed Web of Science ®Google Scholar